Brendan from our Solutions Engineering team explores the current state of HL7® v2 and HL7® FHIR®, and how Redox can drive a FHIR-based application experience even when data exchange partners prefer to use HL7 v2.
Patient engagement. Some would say it’s a myth. Attempts to increase patient involvement in managing their health have…
I use the word incentives a lot, partly because I’m married to an economics professor, and partly…
After a long couple of weeks on the road, I sat down in my window seat and closed…
Interoperability is on the tip of everyone’s tongue in the Health IT space, and every time it…
Many of you reading this are uneasy about blood (stop reading if you’re about to pass out), but…
I’m currently running four email apps on my iPhone. I’ll probably delete a couple of them as I…
